Medtecs International Corporation Limited (9103.TW)

TWD 5.04

(-1.95%)

Gross Profit Summary of Medtecs International Corporation Limited

Medtecs International Corporation Limited's latest annual gross profit in 2023 was 5.95 Million USD , up 278.51% from previous year.
Medtecs International Corporation Limited's latest quarterly gross profit in 2024 Q2 was 3.15 Million USD , up 85.29% from previous quarter.
Medtecs International Corporation Limited reported a annual gross profit of -3.33 Million USD in annual gross profit 2022, down -107.94% from previous year.
Medtecs International Corporation Limited reported a annual gross profit of 42.03 Million USD in annual gross profit 2021, down -75.51% from previous year.
Medtecs International Corporation Limited reported a quarterly gross profit of 5.95 Million USD for 2023 FY, up 278.51% from previous quarter.
Medtecs International Corporation Limited reported a quarterly gross profit of 4.25 Million USD for 2023 Q2, up 136.08% from previous quarter.

Annual Gross Profit Chart of Medtecs International Corporation Limited (2023 - 2009)

Historical Annual Gross Profit of Medtecs International Corporation Limited (2023 - 2009)

Year	Gross Profit	Gross Profit Growth
2023	5.95 Million USD	278.51%
2022	-3.33 Million USD	-107.94%
2021	42.03 Million USD	-75.51%
2020	171.62 Million USD	1529.66%
2019	10.53 Million USD	2.4%
2018	10.28 Million USD	6.26%
2017	9.67 Million USD	4.6%
2016	9.25 Million USD	-6.26%
2015	9.87 Million USD	28.23%
2014	7.69 Million USD	-17.15%
2013	9.29 Million USD	-11.38%
2012	10.48 Million USD	-5.55%
2011	11.09 Million USD	10.05%
2010	10.08 Million USD	-12.12%
2009	11.47 Million USD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	3.15 Million USD	85.29%
2023 FY	5.95 Million USD	278.51%
2023 Q2	4.25 Million USD	136.08%
2023 Q4	1.7 Million USD	-60.07%
2022 Q2	8.46 Million USD	-33.38%
2022 FY	-3.33 Million USD	-107.94%
2022 Q4	-11.8 Million USD	-239.43%
2021 Q4	12.7 Million USD	-58.72%
2021 Q2	30.77 Million USD	-74.41%
2021 FY	42.03 Million USD	-75.51%
2020 Q2	51.42 Million USD	883.4%
2020 Q4	120.24 Million USD	133.84%
2020 FY	171.62 Million USD	1529.66%
2019 Q4	5.22 Million USD	-1.38%
2019 Q2	5.3 Million USD	0.55%
2019 FY	10.53 Million USD	2.4%
2018 Q4	5.27 Million USD	5.23%
2018 FY	10.28 Million USD	6.26%
2018 Q2	5.01 Million USD	13.32%
2017 Q4	4.42 Million USD	-15.87%
2017 Q2	5.25 Million USD	21.39%
2017 FY	9.67 Million USD	4.6%
2016 FY	9.25 Million USD	-6.26%
2016 Q4	4.33 Million USD	-12.03%
2016 Q2	4.92 Million USD	-11.16%
2015 FY	9.87 Million USD	28.23%
2015 Q4	5.54 Million USD	27.94%
2015 Q2	4.33 Million USD	22.32%
2014 Q2	4.15 Million USD	0.34%
2014 FY	7.69 Million USD	-17.15%
2014 Q4	3.54 Million USD	-14.84%
2013 Q4	4.14 Million USD	-19.51%
2013 FY	9.29 Million USD	-11.38%
2013 Q2	5.14 Million USD	0.0%
2012 Q4	- USD	0.0%
2012 FY	10.48 Million USD	-5.55%
2011 Q2	- USD	0.0%
2011 FY	11.09 Million USD	10.05%
2011 Q4	- USD	0.0%
2010 FY	10.08 Million USD	-12.12%
2010 Q4	- USD	0.0%
2009 Q4	- USD	0.0%
2009 FY	11.47 Million USD	0.0%

Peer Gross Profit Comparison of Medtecs International Corporation Limited

Name	Gross Profit	Gross Profit Difference
Nang Kuang Pharmaceutical Co., Ltd.	755.56 Million TWD	99.212%
Maxigen Biotech Inc.	424.09 Million TWD	98.595%
SciVision Biotech Inc.	512.49 Million TWD	98.838%
Bionime Corporation	715.65 Million TWD	99.168%
Pegavision Corporation	3.57 Billion TWD	99.833%
Visco Vision Inc.	857.15 Million TWD	99.305%